Adalimumab in ulcerative colitis: hypes and hopes

Treatment of ulcerative colitis with adalimumab or infliximab: long-term follow-up of a single-centre cohort

(2010) N. Gies et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

409 Adalimumab for Ulcerative Colitis Patients Previously Treated With Infliximab: Outcomes at Short and Long Term and Predictors of Response

(2010) Carlos Taxonera et al.   GASTROENTEROLOGY

Infliximab, Azathioprine, or Combination Therapy for Crohn's Disease

(2010) Jean Frédéric Colombel et al.   NEW ENGLAND JOURNAL OF MEDICINE

Loss of Response and Requirement of Infliximab Dose Intensification in Crohn's Disease: A Review

(2009) Javier P Gisbert et al.   AMERICAN JOURNAL OF GASTROENTEROLOGY

W1132 The Outcome of Active Ulcerative Colitis Treated with Adalimumab

(2009) Nora Hudis et al.   GASTROENTEROLOGY

Influence of Trough Serum Levels and Immunogenicity on Long-term Outcome of Adalimumab Therapy in Crohn's Disease

(2009) Konstantinos Karmiris et al.   GASTROENTEROLOGY

Colectomy Rate Comparison After Treatment of Ulcerative Colitis With Placebo or Infliximab

(2009) William J. Sandborn et al.   GASTROENTEROLOGY

Open-label study of adalimumab in patients with ulcerative colitis including those with prior loss of response or intolerance to infliximab

(2009) Waqqas Afif et al.   INFLAMMATORY BOWEL DISEASES

Adalimumab in ulcerative colitis: Two cases of mucosal healing and clinical response at two years

(2009) Manuel Barreiro-de Acosta et al.   WORLD JOURNAL OF GASTROENTEROLOGY

Long-term outcome of adalimumab therapy for ulcerative colitis with intolerance or lost response to infliximab: a single-centre experience

(2008) A. OUSSALAH et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

Efficacy and Safety of Tumor Necrosis Factor Antagonists in Crohn's Disease: Meta-Analysis of Placebo-Controlled Trials

(2008) Laurent Peyrin–Biroulet et al.   Clinical Gastroenterology and Hepatology

Mechanisms of action of infliximab in inflammatory bowel disease: an anti-inflammatory multitasker

(2008) S. Danese   DIGESTIVE AND LIVER DISEASE

Early combined immunosuppression or conventional management in patients with newly diagnosed Crohn's disease: an open randomised trial

(2008) Geert D'Haens et al.   LANCET

Tumor necrosis factor antagonist mechanisms of action: A comprehensive review

(2007) Daniel Tracey et al.   PHARMACOLOGY & THERAPEUTICS